In one experiment 60% of mice missing something called the gamma interferonreceptor on their cells got tumors after being exposed to a carcinogen, versus only 15% of normal mice.
FORBES: Magazine Article
2.
Anadys Pharmaceuticals is in early-stage human tests with drugs that stimulate the so-called TLR-7 receptor on immune cells to produce interferon just where it is needed.